• 한국정보디스플레이학회:학술대회논문집
• /
• 한국정보디스플레이학회 2009년도 9th International Meeting on Information Display
• /
• pp.830-833
• /
• 2009

We report the synthesis and electroluminescent properties of new aromatic compounds as emitting materials based on indenopyrazine, such 2,8-bis(3,5-diphenylphenyl)-6,6,12,12-tetraethyl-6,12-dihydrodiindeno[1,2-b:1',2'-e]pyrazine (DPP-EPY) and 2,8-bis(3',5'-diphenylbiphenyl-4-yl)-6,6,12,12-tetraethyl-6,12-dihydrodiindeno[1,2-b:1',2'-e]pyrazine (DPBPEPY). DPP-EPY showed high thermal stability, narrow FWHM of 46 nm, luminous efficiency of 1.04 cd/A at current density of 10 mA/$cm^2$ and CIE coordinate of (0.161, 0.104).

• 분석과학
• /
• 제9권3호
• /
• pp.253-261
• /
• 1996

무기시료 중에 게르마늄의 DPP에 의한 미량 분석법이 연구되었다. 1, 2, 3-트리하이드 록시벤젠이 함유된 과염소산 용액 중에 게르마늄(IV)의 환원 피크가 -0.45V(기준전극 Ag/AgCl)에서 나타났고, 이 피크의 높이는 농도에 직선성을 보였다. 게르마늄 분석시에 감도 및 정밀도에 영향을 주는 인자들이 조사되었고, 최적 조건하에서 검출한계는 1ng/ml였다. 무기물 시료들은 potassium pyrosulfate를 사용한 용융법으로 분해하였다. 게르마늄 검출시 Se(IV), Pb(II), As(III)의 간섭에 대한 조사가 있었고, 이들 간섭은 10M HCl용액 중에서 $CCl_4$로 추출함으로써 해결할 수 있었다. 무기물 시료들 (Pb bf. dust, Cu bf. dust, 편마암, Cu anode slime)중의 게르마늄 함량은 위의 방법으로 정량되었다.

• The Korean Journal of Physiology and Pharmacology
• /
• 제23권5호
• /
• pp.329-334
• /
• 2019

Diabetes is associated with an increased risk of cardiovascular complications. Dipeptidyl peptidase-4 (DPP-IV) inhibitors are used clinically to reduce high blood glucose levels as an antidiabetic agent. However, the effect of the DPP-IV inhibitor gemigliptin on ischemia/reperfusion (I/R)-induced myocardial injury and hypertension is unknown. In this study, we assessed the effects and mechanisms of gemigliptin in rat models of myocardial I/R injury and spontaneous hypertension. Gemigliptin (20 and 100 mg/kg/d) or vehicle was administered intragastrically to Sprague-Dawley rats for 4 weeks before induction of I/R injury. Gemigliptin exerted a preventive effect on I/R injury by improving hemodynamic function and reducing infarct size compared to the vehicle control group. Moreover, administration of gemigliptin (0.03% and 0.15%) powder in food for 4 weeks reversed hypertrophy and improved diastolic function in spontaneously hypertensive rats. We report here a novel effect of the gemigliptin on I/R injury and hypertension.

• 생약학회지
• /
• 제52권2호
• /
• pp.77-83
• /
• 2021

The number of people suffering from diabetes have been increased around the world. In this study, we investigated the antidiabetic and antioxidant effects of Anthriscus sylvestris(L.) Hoffm and its main compounds. It was divided into root(R) and aerial part(AP) for comparative analysis. Total polyphenol, total flavonoid content was higher in AP extract, but nodakenin content was higher in R(1169.13 ± 6.00 mg/g) extract. Antioxidant activity was also higher in AP extract. To compare antidiabetic efficacy, we analyzed the effects of R and AP extracts on ɑ-glucosidase inhibition(AGI), dipeptidyl peptidase-4(DPP-4) and protein tyrosine phosphatase(PTP)1B activity. R and AP extracts showed similar effects on AGI and DPP-4 activity in a concentration dependent manner, and there was no effect on PTP1B activation. Glucose uptake(139.51 ± 3.19%) in 3T3-L1 cells was more effective in the AP extract-treated group than the positive control, rosiglitazone, group. Both R and AP extracts were effective in protecting against pancreatic beta cell damage caused by hyperglycemia. These results suggest that Anthriscus sylvestris(L.) Hoffm. could be used as a candidate for diabetes treatment.

• 한국가축번식학회지
• /
• 제25권4호
• /
• pp.305-315
• /
• 2001

본 연구의 목적은 외래 EGFP 유전자를 분화이전의 웅성생식세포에 도입한 후 이를 난모세포내에 미세주입하여 형질전환동물을 생산하는 기술을 개발하는 데에 있다. 이를 위하여 반수체 정자세포에서 특이적으로 발현하는 생쥐의 mTP1과 햄스터의 hPrm2 유전자 발현 시기를 RT-PCR로 조사한 결과 그시기는 생쥐와 햄스터에서 각각 18일령과 20일령으로 확인되었다. 이에 따라 외래 유전자의 침입이 용이한 감수분열 직전단계인 17일령의 생쥐와 19일령의 햄스터 정자세포를 EGFP 유전자가 포함된 배양액에 부유시킨 다음, 전기자극을 부여한 결과 0.18 ㎸/cm의 전기자극을 가한 후 72시간 배양한 정자세포의 28.5%와 32.1%에서 EGFP 유전자가 발현되는 것으로 확인되었다. EGFP유전자가 도입된 반수체 정자의 수정 및 발달 능력을 검증하기 위하여, 이들 정자세포를 햄스터 난자 내에 미세주입 하였으나, 형광현미경하에서는 EGFP유전자의 발현은 관찰할 수 없었다. 이에 이들 난자를 공시하여 PCR분석을 실시한 결과, 약 44%의 수정란에서 EGFP 유전자의 존재가 확인되었다. 이러한 결과로 보아 반수체 정자세포는 외래 유전자를 난자 내에 도입하기 위한 운반체로 이용될 수 있을 것으로 생각된다.

• 한국축산식품학회지
• /
• 제43권2호
• /
• pp.232-244
• /
• 2023

We investigated the effects of different phosphate replacements on the quality of ground pork products cured with sodium nitrite or radish powder to determine their potential for achieving clean-label pork products. The experimental design was a 2×5 factorial design. For this purpose, the ground meat mixture was assigned into two groups, depending on nitrite source. Each group was mixed with 0.01% sodium nitrite or 0.4% radish powder together with 0.04% starter culture, and then processed depending on phosphate replacement [with or without 0.5% sodium tripolyphosphate; STPP (+), STPP (-), 0.5% oyster shell calcium (OSC), 0.5% citrus fiber (CF), or 0.5% dried plum powder (DPP)]. All samples were cooked, cooled, and stored until analysis within two days. The nitrite source had no effect on all dependent variables of ground pork products. However, in phosphate replacement treatments, the STPP (+) and OSC treatments had a higher cooking yield than the STPP (-), CF, or DPP treatments. OSC treatment was more effective for lowering total fluid separation compared to STPP (-), CF, or DPP treatments, but had a higher percentage than STPP (+). The STPP (+) treatment did not differ from the OSC or CF treatments for CIE L^* and CIE a^*. Moreover, no differences were observed in nitrosyl hemochrome content, lipid oxidation, hardness, gumminess, and chewiness between the OSC and STPP (+) treatments. In conclusion, among the phosphate replacements, OSC addition was the most suitable to provide clean-label pork products cured with radish powder as a synthetic nitrite replacer.

• 한국환경농학회지
• /
• 제30권3호
• /
• pp.261-267
• /
• 2011

인산에 의한 카드뮴의 식물저감 효과를 증진시키기 위해 서로 다른 특성의 두 인산제재인 용과린과 $K_2HPO_4$를 선정하여 축분퇴비와 혼용하여 처리한 후 알타리무 내 카드뮴 흡수특성과 토양 내 카드뮴의 특성을 조사하였다. $K_2HPO_4$는 토양의 pH와 음하전도를 증대시켜 토양 내 유효태 카드뮴 함량과 알타리무내 카드뮴 흡수농도를 저감시키는 효과를 나타내었다. 반면 용과린은 토양의 pH와 음하전도를 감소시켜 유효태 카드뮴 함량과 알타리무 내 카드뮴 함량을 증가시키는 효과를 나타내었다. 축분퇴비와 인산비료와의 혼용은 인산 제재의 특성에 관계없이 인산비료를 단독으로 시용하였을 때 보다 알타리무 내 카드뮴 흡수농도와 토양 내 유효태 카드뮴 함량을 감소시키는 효과가 훨씬 우수한 것으로 나타났다. 인산비료나 축분퇴비의 시용에 의해 토양 내 인산과 카드뮴의 침전반응에 의한 난용성의 카드뮴 화합물의 형성은 나타나지 않았다. 토양의 pH와 음하전도는 토양 내 유효태 카드뮴의 함량과 알타리무 내 카드뮴의 함량과 고도로 유의한 부의 상관관계를 나타내었다. 본 연구의 결과를 통하여 인산비료와 축분퇴비에 의한 카드뮴의 부동화는 인산과 카드뮴의 직접적인 침전반응에 의한 것이라기보다는 토양의 pH와 음하전도의 증대에 기인된 카드뮴의 흡착증대에 의한 것으로 판단되어진다.

• KSBB Journal
• /
• 제32권1호
• /
• pp.35-45
• /
• 2017

In this work the optical fiber glucose and lactate biosensors were developed by using fluorescent dye and enzyme immobilized on the end tip of an optical fiber. 3-Glycidyloxypropyl)methyldiethoxysilane (GPTMS), (3-Aminopropyl) trimethoxysilane (APTMS) and Methyltrimethoxysilane (MTMS) were used to immobilize glucose oxidase (GOD), lactate oxidase (LOD) and ruthenium(II) complex (tris(4,7-diphenyl-1,10-phenanthroline) ruthenium(II), $Ru(dpp)_3^{2+}$) as oxygen sensitive fluorescent dye. MTMS sol-gel was an excellent supporting material for the immobilization of $Ru(dpp)_3^{2+}$, GOD, and LOD on the optical fiber. Storage stability of the optical fiber glucose sensor was kept constant over 20 days, while the optical fiber lactate sensor had constant storage stability over 17 days. The optical fiber glucose and lactate biosensors also maintained good operational stability for 20 hours and 14 hours, respectively. The activities of the immobilized enzymes were most excellent at pH 7 and at $25^{\circ}C$. On-line monitoring of glucose and lactate in a simulated process was performed with the optical fiber glucose and lactate biosensors. On-line monitoring results were agreed with those of off-line data measured with high performance liquid chromatography (HPLC).

• The Korean Journal of Physiology and Pharmacology
• /
• 제22권6호
• /
• pp.713-719
• /
• 2018

Dipeptidyl peptidase4 (DPP4) inhibitors such as gemigliptin are antidiabetic drugs elevating plasma concentration of incretins such as GLP-1. In addition to the DPP4 inhibition, gemigliptin might directly improve the functions of vessels under pathological conditions. To test this hypothesis, we investigated whether the acetylcholine-induced endothelium dependent relaxation (ACh-EDR) of mesenteric arteries (MA) are altered by gemigliptin pretreatment in Spontaneous Hypertensive Rats (SHR) and in Wistar-Kyoto rats (WKY) under hyperglycemia-like conditions (HG; 2 hr incubation with 50 mM glucose). ACh-EDR of WKY was reduced by the HG condition, which was significantly recovered by $1{\mu}M$ gemigliptin while not by saxagliptin and sitagliptin up to $10{\mu}M$. The ACh-EDR of SHR MA was also improved by $1{\mu}M$ gemigliptin while similar recovery was observed with higher concentration ($10{\mu}M$) of saxagliptin and sitagliptin. The facilitation of ACh-EDR by gemigliptin in SHR was not observed under pretreatment with NOS inhibitor, L-NAME. In the endothelium-denuded MA of SHR, sodium nitroprusside induced dose-dependent relaxation was not affected by gemigliptin. The ACh-EDR in WKY was decreased by treatment with $30{\mu}M$ pyrogallol, a superoxide generator, which was not prevented by gemigliptin. Exendin-4, a GLP-1 analogue, could not enhance the ACh-EDR in SHR MA. The present results of ex vivo study suggest that gemigliptin enhances the NOS-mediated EDR of the HG-treated MA as well as the MA from SHR via GLP-1 receptor independent mechanism.

• Biomolecules & Therapeutics
• /
• 제26권2호
• /
• pp.201-209
• /
• 2018

G protein-coupled receptor 119 (GPR119) is expressed in the pancreas and gastrointestinal tract, and its activation promotes insulin secretion in the beta cells of the pancreatic islets as well as the secretion of glucagon-like peptide-1 (GLP-1) in intestinal L cells, consequently improving glucose-stimulated insulin secretion. Due to this dual mechanism of action, the development of small-molecule GPR119 agonists has received significant interest for the treatment of type 2 diabetes. We newly synthesized 1,2,4-triazolone derivatives of GPR119 agonists, which demonstrated excellent outcomes in a cyclic adenosine monophosphate (cAMP) assay. Among the synthesized derivatives, YH18968 showed cAMP=2.8 nM; in GLUTag cell, GLP-1secretion=2.3 fold; in the HIT-T15 cell, and insulin secretion=1.9 fold. Single oral administration of YH18968 improved glucose tolerance and combined treatment with a dipeptidyl peptidase 4 (DPP-4) inhibitor augmented the glucose lowering effect as well as the plasma level of active GLP-1 in normal mice. Single oral administration of YH18968 improved glucose tolerance in a diet induced obese mice model. This effect was maintained after repeated dosing for 4 weeks. The results indicate that YH18968 combined with a DPP-4 inhibitor may be an effective therapeutic candidate for the treatment of type 2 diabetes.